Leritrelvir

DESCRIPTION

Leritrelvir (RAY1216) is a potent orally active inhibitor of the SARS-CoV-2 main protease, exhibiting a slow-tight binding mechanism with an inhibition constant (Ki) of 8.6 nM [1].

DETAILS

Cas: 2923310-64-7
Purity: 98%
Smiles: C1CCC(CC1)[C@@H](C(=O)N2C[C@@H]3CCC[C@@H]3[C@H]2C(=O)N[C@@H](C[C@@H]4CCNC4=O)C(=O)C(=O)NC5CCCC5)NC(=O)C(F)(F)F
Category: Compound
Molecular Weight: 639.71
Molecular Formula: C31H44F3N5O6

Lead Time: 4 - 5 weeks